Analysts issued mixed ratings updates for several companies. Insulet and Bristol Myers Squibb saw price targets lowered or set with neutral ratings, while Westlake and Martin Marietta Materials received positive upgrades and increased targets. Cognex was also upgraded by multiple firms.
Comments